{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:32:03Z","timestamp":1793053923273,"version":"4.5.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T00:00:00Z","timestamp":1420502400000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Response to hydroxyurea therapy in homozygous or compound heterozygous beta thalassaemia (BT) has been reported as more favourable in the presence of XmnI polymorphism. The prevalence of XmnI polymorphism may vary with BT phenotypes and genotypes, and differs geographically in distribution. Prevalence of XmnI polymorphism is not known in northern Pakistan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To determine the frequency of Gc-globin promoter \u2013158 (C&gt;T) XmnI polymorphism (XmnI polymorphism) in patients with homozygous or compound heterozygous beta thalassaemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS:<\/jats:title>\n                    <jats:p>Polymerase chain reaction (PCR) for common beta thalassaemia mutations and Gc-globin promoter \u2013158 (C&gt;T) XmnI polymorphism was performed on 107 blood samples of transfusion dependent beta thalassaemia (BT) patients in Pakistan. One hundred samples of unrelated BT traits and 94 samples of healthy subjects as controls were also analysed for BT mutations and XmnI polymorphism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Out of 301 DNA samples, XmnI polymorphism was detected in 71(24%); in normal controls, XmnI polymorphism was detected in 34\/94 (36%) subjects; while in homozygous\/compound heterozygous BT, it was detected in 14\/107(13%) patients (Fisher's exact test,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = .0002). In heterozygous BT group, XmnI polymorphism was detected in 23\/100 subjects (Fisher's exact test,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = .03 with normal controls, and\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = .049 with homozygous\/compound heterozygous BT). The most common BT genotype was Frame Shift (Fr) 8-9\/Fr 8-9, and none of the patients with this genotype had XmnI polymorphism. The second most common genotype was IVSI-5\/IVSI-5; 4\/26 (15%). Cases with this genotype had XmnI polymorphism.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>XmnI polymorphism in homozygous\/compound heterozygous BT group is 13%. The most common genotype associated with XmnI polymorphism was IVSI-5\/IVSI-5.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.hemonc.2014.12.004","type":"journal-article","created":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T12:56:58Z","timestamp":1420549018000},"page":"10-15","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Frequency of Gc-globin promoter \u2013158 (C&gt;T) XmnI polymorphism in patients with homozygous\/compound heterozygous beta thalassaemia"],"prefix":"10.4103","volume":"8","author":[{"given":"Nadir","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ayyub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleem Ahmed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhaib","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazim","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Saeed","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunila","family":"Tashfeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"2","key":"10.1016\/j.hemonc.2014.12.004_b0005","first-page":"32","article-title":"Prevalence of heterozygous beta-thalassemia in northern areas of Pakistan","volume":"42","author":"Khattak","year":"1992","journal-title":"J Pak Med Assoc"},{"issue":"2","key":"10.1016\/j.hemonc.2014.12.004_b0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/0971-6866.100762","article-title":"Molecular epidemiology of \u03b2-thalassemia in Pakistan: far reaching implications","volume":"18","author":"Ansari","year":"2012","journal-title":"Indian J Hum Genet"},{"issue":"1","key":"10.1016\/j.hemonc.2014.12.004_b0015","first-page":"40","article-title":"Prevalence of various mutations in beta thalassaemia and its association with haematological parameters","volume":"62","author":"Khattak","year":"2012","journal-title":"J Pak Med Assoc"},{"issue":"3","key":"10.1016\/j.hemonc.2014.12.004_b0020","first-page":"ELT02","article-title":"Spectrum of beta-thalassemia mutations in various regions of Punjab and Islamabad, Pakistan: establishment of prenatal diagnosis","volume":"91","author":"Baig","year":"2006","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.hemonc.2014.12.004_b0025","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3324\/haematol.2011.046748","article-title":"Variants in genetic modifiers of \u03b2-thalassemia can help to predict the major or intermedia type of the disease","volume":"96","author":"Badens","year":"2011","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.hemonc.2014.12.004_b0030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bcmd.2010.04.002","article-title":"The XmnI (G) gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients","volume":"45","author":"Nguyen","year":"2010","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"10.1016\/j.hemonc.2014.12.004_b0035","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1182\/blood-2003-01-0117","article-title":"Hydroxyurea can eliminate transfusion requirements in children with severe beta-thalassemia","volume":"102","author":"Bradai","year":"2003","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hemonc.2014.12.004_b0040","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.exphem.2008.06.014","article-title":"A cell stress signaling model of fetal hemoglobin induction: what does not kill red blood cells may make them stronger","volume":"36","author":"Mabaera","year":"2008","journal-title":"Exp Hematol"},{"issue":"1","key":"10.1016\/j.hemonc.2014.12.004_b0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12185-011-0985-6","article-title":"Genotype-phenotype relationship of patients with \u03b2-thalassemia taking hydroxyurea: a 13-year experience in Iran","volume":"95","author":"Karimi","year":"2012","journal-title":"Int J Hematol"},{"issue":"4","key":"10.1016\/j.hemonc.2014.12.004_b0050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/03630260701641245","article-title":"Multicenter study of the molecular basis of thalassemia intermedia in different ethnic populations","volume":"31","author":"Verma","year":"2007","journal-title":"Hemoglobin"},{"issue":"6","key":"10.1016\/j.hemonc.2014.12.004_b0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1600-0609.2010.01422.x","article-title":"Evaluation of the genetic basis of phenotypic heterogeneity in north Indian patients with thalassemia major","volume":"84","author":"Sharma","year":"2010","journal-title":"Eur J Hematol"},{"issue":"2","key":"10.1016\/j.hemonc.2014.12.004_b0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bcmd.2010.11.002","article-title":"Xmn I polymorphism associated with concomitant activation of G\u03b3 and A\u03b3 globin gene transcription on a \u03b20-thalassemia chromosome","volume":"46","author":"Haj Khelil","year":"2011","journal-title":"Blood Cells Mol Dis"},{"issue":"10","key":"10.1016\/j.hemonc.2014.12.004_b0065","first-page":"1172","article-title":"Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients","volume":"89","author":"Yavarian","year":"2004","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.hemonc.2014.12.004_b0070","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1182\/blood-2012-10-408021","article-title":"Clinical experience with fetal hemoglobin induction therapy in patients with \u03b2-thalassemia","volume":"121","author":"Musallam","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hemonc.2014.12.004_b0075","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3324\/haematol.2011.053504","article-title":"Genetic modifiers of \u03b2-thalassemia and clinical severity as assessed by age at first transfusion","volume":"97","author":"Danjou","year":"2012","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.hemonc.2014.12.004_b0080","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MPH.0b013e31821b0770","article-title":"Efficacy of hydroxyurea in providing transfusion independence in \u03b2-thalassemia","volume":"33","author":"Ansari","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.hemonc.2014.12.004_b0085","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1097\/MPH.0b013e31827e8662","article-title":"G\u03b3-Xmn I polymorphism: a significant determinant of \u03b2-thalassemia treatment without blood transfusion","volume":"35","author":"Ansari","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.hemonc.2014.12.004_b0090","first-page":"139","article-title":"Relation of Xmn-1 polymorphism and five common Indian mutations of thalassaemia with phenotypic presentation in \u03b2-thalassaemia","volume":"8","author":"Aditya","year":"2006","journal-title":"JK Sci"},{"issue":"2","key":"10.1016\/j.hemonc.2014.12.004_b0095","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1081\/HEM-120005452","article-title":"Beta-thalassemia intermedia from southern Iran: IVS-II-1 (G\u2192A) is the prevalent thalassemia intermedia allele","volume":"26","author":"Karimi","year":"2002","journal-title":"Hemoglobin"},{"issue":"2","key":"10.1016\/j.hemonc.2014.12.004_b0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bcmd.2009.10.007","article-title":"Frequency of positive XmnIGgamma polymorphism and coinheritance of common alpha thalassemia mutations do not show statistically significant difference between thalassemia major and intermedia cases with homozygous IVSII-1 mutations","volume":"44","author":"Neishabury","year":"2010","journal-title":"Blood Cells Mol Dis"},{"issue":"12","key":"10.1016\/j.hemonc.2014.12.004_b0105","first-page":"1927","article-title":"Frequency of G\u03b3-globin promoter \u2212158 (C>T) Xmn I polymorphism in Denizli, Turkey","volume":"7","author":"Bahadir","year":"2012","journal-title":"Int J Phys Sci"},{"issue":"5","key":"10.1016\/j.hemonc.2014.12.004_b0110","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5144\/0256-4947.2012.487","article-title":"Prevalence of Xmnl G\u03b3 polymorphism in Egyptian patients with \u03b2-thalassemia major","volume":"32","author":"Tantawy","year":"2012","journal-title":"Ann Saudi Med"},{"issue":"4","key":"10.1016\/j.hemonc.2014.12.004_b0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ajh.20376","article-title":"XmnI Ggamma-polymorphism in six unrelated Pakistani families with Inv\/Del Ggamma(Agammadeltabeta) degrees deltabeta-thalassemia","volume":"80","author":"Ahmed","year":"2005","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.hemonc.2014.12.004_b0120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/03630260701285050","article-title":"Genotypic correlation between six common beta-thalassemia mutations and the XmnI polymorphism in the Moroccan population","volume":"31","author":"Agouti","year":"2007","journal-title":"Hemoglobin"},{"issue":"4","key":"10.1016\/j.hemonc.2014.12.004_b0125","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12288-013-0293-9","article-title":"Influence of Xmn 1(G)\u03b3 (HBG2 c.-211 C\u2192T) Globin Gene Polymorphism on Phenotype of Thalassemia Patients of North India","volume":"30","author":"Kumar","year":"2014","journal-title":"Indian J Hematol Blood Transfus"}],"container-title":["Hematology\/Oncology and Stem Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387614001149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387614001149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/02275670-201508010-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:50:09Z","timestamp":1787838609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02275670-201508010-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1016\/j.hemonc.2014.12.004","relation":{},"ISSN":["1658-3876"],"issn-type":[{"value":"1658-3876","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}